(NASDAQ: ACET) Adicet Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.88%.
Adicet Bio's earnings in 2026 is -$98,974,000.On average, 8 Wall Street analysts forecast ACET's earnings for 2026 to be -$63,546,730, with the lowest ACET earnings forecast at -$70,917,031, and the highest ACET earnings forecast at -$55,340,448. On average, 7 Wall Street analysts forecast ACET's earnings for 2027 to be -$47,552,625, with the lowest ACET earnings forecast at -$59,540,949, and the highest ACET earnings forecast at -$36,467,684.
In 2028, ACET is forecast to generate -$35,202,947 in earnings, with the lowest earnings forecast at -$42,109,854 and the highest earnings forecast at -$27,522,781.